Literature DB >> 9214258

Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians.

M Linzer1, E H Yang, N A Estes, P Wang, V R Vorperian, W N Kapoor.   

Abstract

PURPOSE: To review the literature on diagnostic testing in syncope that remains unexplained after initial clinical assessment. DATA SOURCES: MEDLINE search. STUDY SELECTION: Published papers were selected if they addressed diagnostic testing in syncope, near syncope, or dizziness. DATA EXTRACTION: Studies were identified as population studies, referral studies, or case series. DATA SYNTHESIS: After a thorough history, physical examination, and electrocardiography, the cause of syncope remains undiagnosed in 50% of patients. In such patients, information may be derived from the results of carefully selected diagnostic tests, especially 1) electrophysiologic studies in patients with organic heart disease, 2) Holter monitoring or telemetry in patients known to have or suspected of having heart disease, 3) loop monitoring in patients with frequent events and normal hearts, 4) psychiatric evaluation in patients with frequent events and no injury, and 5) tilt-table testing in patients who have infrequent events or in whom vasovagal syncope is suspected. Hospitalization is indicated for high-risk patients, especially those with known heart disease and elderly patients.
CONCLUSIONS: A flexible, focused approach is required to diagnose syncope. Features of the initial history and physical examination help guide diagnostic testing.

Entities:  

Mesh:

Year:  1997        PMID: 9214258     DOI: 10.7326/0003-4819-127-1-199707010-00014

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  45 in total

Review 1.  Current investigations used to assess syncope.

Authors:  W Arthur; G C Kaye
Journal:  Postgrad Med J       Date:  2001-01       Impact factor: 2.401

2.  The utility of head computed tomography in the emergency department evaluation of syncope.

Authors:  Nikhil Goyal; Michael W Donnino; Ravi Vachhani; Ravi Bajwa; Tabassum Ahmad; Ronny Otero
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

3.  [Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004].

Authors:  K Seidl; A Schuchert; J Tebbenjohanns; W Hartung
Journal:  Z Kardiol       Date:  2005-09

Review 4.  Diagnosis and treatment of syncope.

Authors:  Michele Brignole
Journal:  Heart       Date:  2007-01       Impact factor: 5.994

5.  Guidelines for the diagnosis and management of syncope (version 2009).

Authors:  Angel Moya; Richard Sutton; Fabrizio Ammirati; Jean-Jacques Blanc; Michele Brignole; Johannes B Dahm; Jean-Claude Deharo; Jacek Gajek; Knut Gjesdal; Andrew Krahn; Martial Massin; Mauro Pepi; Thomas Pezawas; Ricardo Ruiz Granell; Francois Sarasin; Andrea Ungar; J Gert van Dijk; Edmond P Walma; Wouter Wieling
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

6.  Role of echocardiography in the evaluation of syncope: a prospective study.

Authors:  F P Sarasin; A-F Junod; D Carballo; S Slama; P-F Unger; M Louis-Simonet
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 7.  Syncope: investigation and treatment.

Authors:  Satish R Raj; Robert S Sheldon
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

Review 8.  Epidemiology of reflex syncope.

Authors:  N Colman; K Nahm; K S Ganzeboom; W K Shen; J Reitsma; M Linzer; W Wieling; H Kaufmann
Journal:  Clin Auton Res       Date:  2004-10       Impact factor: 4.435

9.  Role of brain natriuretic peptide (BNP) in risk stratification of adult syncope.

Authors:  Matthew J Reed; David E Newby; Andrew J Coull; Keith G Jacques; Robin J Prescott; Alasdair J Gray
Journal:  Emerg Med J       Date:  2007-11       Impact factor: 2.740

10.  Cardiovascular assessment of falls in older people.

Authors:  Maw Pin Tan; Rose Anne Kenny
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.